Rachel Bluth

Anti-vaccine advocates have repurposed a catchy, succinct, and potent slogan. Its unlikely source: the reproductive rights movement, which has been linked to the phrase for more than 50 years.

As California's attorney general, Xavier Becerra fought Trump-era restrictions on reproductive health. If confirmed, he'll navigate an even more difficult legal and political landscape.

Access to testing is still uneven in the nation's largest state. Even as some urban counties offer tests to anyone who wants one, a rural county is testing raw sewage to track the virus.

Lawmakers in both parties are trying to balance the competing needs of powerful stakeholders and consumers stuck with high bills. Despite progress, many insiders expect work to continue into 2020.

As Congress considers legislation to end surprise medical billing, some are looking at lessons learned from New York's experiment with "baseball-style" arbitration.

Patients are often told to be smart consumers and shop around for health care before they use it. But even when you do so, estimates from insurers, hospitals and doctors can be unreliable.

The median air ambulance bill is more than $36,000 and is seldom covered by health plans. So far, legislative hurdles and industry pressure have kept Congress from stepping in.

The bipartisan legislation proposes plans to deal with surprise medical bills, prescription drug patents, price transparency and vaccine education.

Lawmakers are discussing several measures to solve the problem of unexpected medical bills, which can wreak havoc on patients' lives. Here's our guide to the current roster of proposed legislation.

Surprise billing is one of the rare public policy issues that are both bipartisan and in need of a federal solution. A hearing on Capitol Hill looked to insurers and providers to help figure it out.

An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer, an analysis by Kaiser Health News reveals.

Eight percent of respondents in a recent national poll said they or someone in their household had imported a prescription drug to the U.S. at some point. Are the deals as good as they seem?

The Democrats' vice presidential nominee helped overhaul Virginia's mental health care system after the 2007 shootings at Virginia Tech. He is for Obamacare, Medicaid expansion and Planned Parenthood.

A simplified form should make it easier for doctors to treat seriously ill patients with experimental drugs after other options run out. But that's not the only obstacle to compassionate use.